NASDAQ : OFIX
Orthofix Medical Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 9.07 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 369.44M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 369.44M |
| Enterprise Value | 527.53M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 40.73M |
| Shares Outstanding | 40.73M |
| Shares Change (YoY) | +3.56% |
| Shares Change (QoQ) | +1.13% |
| Owned by Insiders (%) | 0.80% |
| Owned by Institutions (%) | 55.30% |
| Float | 40.41M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 14.63 |
| PS Ratio | 0.44 |
| Forward PS | 0.43 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 2.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 22.71 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.63 |
| EV / EBITDA | 25.21 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.84 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 9.03 |
| Debt / FCF | n/a |
| Interest Coverage | -1.81 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -13.91% |
| Return on Assets (ROA) | -2.75% |
| Return on Invested Capital (ROIC) | -6.45% |
| Return on Capital Employed (ROCE) | -5.25% |
| Weighted Average Cost of Capital (WACC) | 7.08% |
| Revenue Per Employee | $519,119 |
| Profits Per Employee | -$38,457 |
| Employee Count | 1,605 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 1.34 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.44M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -40.80% |
| 50-Day Moving Average | 9.39 |
| 200-Day Moving Average | 11.10 |
| Relative Strength Index (RSI) | 42.30 |
| Average Volume (20 Days) | 385,745 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.39M |
| Short Previous Month | 2.44M |
| Short % of Shares Out | 5.87% |
| Short % of Float | 5.92% |
| Short Ratio (days to cover) | 5.61 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 833.19M |
| Gross Profit | 593.73M |
| Operating Income | -37.56M |
| Pretax Income | -60.29M |
| Net Income | -61.72M |
| EBITDA | 20.93M |
| EBIT | -37.56M |
| Loss Per Share | -$1.53 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 103.81M |
| Total Debt | 261.90M |
| Net Cash | -158.09M |
| Net Cash Per Share | -$3.88 |
| Equity (Book Value) | 429.18M |
| Book Value Per Share | 10.54 |
| Working Capital | 289.12M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 16.27M |
| Capital Expenditures | -44.09M |
| Depreciation & Amortization | 58.49M |
| Net Borrowing | 63.58M |
| Free Cash Flow | -27.82M |
| FCF Per Share | -$0.68 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.26% |
| Operating Margin | -4.51% |
| Pretax Margin | -7.24% |
| Profit Margin | -7.41% |
| EBITDA Margin | 2.51% |
| EBIT Margin | -4.51% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.56% |
| Shareholder Yield | -3.56% |
| Earnings Yield | -16.89% |
| FCF Yield | -7.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.00 |
| Price Target Difference | 43.33% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 3.73% |
| EPS Growth Forecast (3Y) | -10.45% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.27 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |